AGENUS INC Weighted Average Number of Shares Outstanding, Basic and Diluted
AGENUS INC (AGEN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 258.31 thousand shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- AGENUS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 258.31K shares, a 28.94% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 222.91M shares, a 31.80% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 200.33K shares, a 99.86% decline year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was -496.36M shares.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 228.92K shares, a 32.70% increase from fiscal 2020.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 172.50K shares, a 27.80% increase from fiscal 2019.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 134.98K shares, a 21.86% increase from fiscal 2018.
- AGENUS INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 110.77K shares, a 12.56% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | 258.31K shares 10-Q · filed 2022-05-10 | ||||||
| 2021-12-31 | 228.92K shares 10-K · filed 2022-03-01 | ||||||
| 2021-06-30 | 222.91M shares 10-Q · filed 2021-08-09 | 211.68M shares 10-Q · filed 2021-08-09 | -91.08M shares derived: average of 3 quarters · filed 2022-05-10 | -22.65M shares derived: average of 4 quarters · filed 2022-05-10 | |||
| 2021-03-31 | 200.33K shares 10-Q · filed 2022-05-10 | 200.33M shares 10-Q · filed 2021-05-07 | -248.08M shares derived: average of 2 quarters · filed 2022-05-10 | -104.50M shares derived: average of 3 quarters · filed 2022-05-10 | -36.09M shares derived: average of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -496.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -156.84M shares derived: average of 2 quarters · filed 2022-03-01 | -48.19M shares derived: average of 3 quarters · filed 2022-03-01 | 172.50K shares 10-K · filed 2022-03-01 | |||
| 2020-09-30 | 182.67M shares 10-Q · filed 2020-11-09 | 175.90M shares derived: average of 2 quarters · filed 2021-08-09 | 165.68M shares 10-Q · filed 2020-11-09 | 23.84M shares derived: average of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | 169.13M shares 10-Q · filed 2021-08-09 | 157.10M shares 10-Q · filed 2021-08-09 | -29.10M shares derived: average of 3 quarters · filed 2022-03-01 | 12.58M shares derived: average of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | 145.06M shares 10-Q · filed 2021-05-07 | -128.22M shares derived: average of 2 quarters · filed 2022-03-01 | -39.61M shares derived: average of 3 quarters · filed 2022-03-01 | 3.95M shares derived: average of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -401.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -131.94M shares derived: average of 2 quarters · filed 2022-03-01 | -43.08M shares derived: average of 3 quarters · filed 2022-03-01 | 134.98K shares 10-K · filed 2022-03-01 | |||
| 2019-09-30 | 137.62M shares 10-Q · filed 2020-11-09 | 136.13M shares derived: average of 2 quarters · filed 2020-11-09 | 134.01M shares 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | 134.64M shares 10-Q · filed 2020-08-10 | 132.18M shares 10-Q · filed 2020-08-10 | |||||
| 2018-12-31 | -322.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -103.69M shares derived: average of 2 quarters · filed 2021-03-16 | -34.09M shares derived: average of 3 quarters · filed 2021-03-16 | 110.77K shares 10-K · filed 2021-03-16 | 110.77M shares 10-K · filed 2019-03-18 | ||
| 2018-09-30 | 114.98M shares 10-Q · filed 2019-11-07 | 114.98M shares 10-Q · filed 2018-11-07 | 110.05M shares derived: average of 2 quarters · filed 2019-11-07 | 107.60M shares 10-Q · filed 2019-11-07 | 7.60M shares derived: average of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | 105.11M shares 10-Q · filed 2019-08-09 | 105.11M shares 10-Q · filed 2018-08-09 | 103.85M shares 10-Q · filed 2019-08-09 | 103.85M shares 10-Q · filed 2018-08-09 | -28.20M shares derived: average of 3 quarters · filed 2020-03-16 | 3.83M shares derived: average of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | 102.58M shares 10-Q · filed 2018-05-10 | -94.85M shares derived: average of 2 quarters · filed 2020-03-16 | -29.94M shares derived: average of 3 quarters · filed 2020-03-16 | 2.35M shares derived: average of 4 quarters · filed 2020-03-16 | |||
| 2017-12-31 | -292.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -96.19M shares derived: average of 2 quarters · filed 2020-03-16 | -31.06M shares derived: average of 3 quarters · filed 2020-03-16 | 98.42K shares 10-K · filed 2020-03-16 | 98.42M shares 10-K · filed 2018-03-16 | ||
| 2017-09-30 | 99.89M shares 10-Q · filed 2018-11-07 | 99.55M shares derived: average of 2 quarters · filed 2018-11-07 | 97.56M shares 10-Q · filed 2018-11-07 | 95.01M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | 99.20M shares 10-Q · filed 2018-08-09 | 96.37M shares 10-Q · filed 2018-08-09 | 93.38M shares derived: average of 3 quarters · filed 2019-03-18 | 91.83M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | 93.51M shares 10-Q · filed 2018-05-10 | 90.46M shares derived: average of 2 quarters · filed 2019-03-18 | 89.38M shares derived: average of 3 quarters · filed 2019-03-18 | 88.77M shares derived: average of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | 87.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 87.31M shares derived: average of 2 quarters · filed 2019-03-18 | 87.20M shares derived: average of 3 quarters · filed 2019-03-18 | 87.07M shares 10-K · filed 2019-03-18 | |||
| 2016-09-30 | 87.21M shares 10-Q · filed 2017-11-07 | 87.09M shares derived: average of 2 quarters · filed 2017-11-07 | 86.95M shares 10-Q · filed 2017-11-07 | 86.47M shares derived: average of 4 quarters · filed 2018-03-16 | |||
| 2016-06-30 | 86.96M shares 10-Q · filed 2017-08-07 | 86.83M shares 10-Q · filed 2017-08-07 | 86.23M shares derived: average of 3 quarters · filed 2018-03-16 | 85.82M shares derived: average of 4 quarters · filed 2018-03-16 | |||
| 2016-03-31 | 86.69M shares 10-Q · filed 2017-05-04 | 85.86M shares derived: average of 2 quarters · filed 2018-03-16 | 85.43M shares derived: average of 3 quarters · filed 2018-03-16 | 83.17M shares derived: average of 4 quarters · filed 2018-03-16 | |||
| 2015-12-31 | 85.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 84.80M shares derived: average of 2 quarters · filed 2018-03-16 | 81.99M shares derived: average of 3 quarters · filed 2018-03-16 | 78.21M shares 10-K · filed 2018-03-16 | |||
| 2015-09-30 | 84.57M shares 10-Q · filed 2016-11-09 | 80.47M shares derived: average of 2 quarters · filed 2016-11-09 | 75.94M shares 10-Q · filed 2016-11-09 | 72.62M shares derived: average of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | 76.37M shares 10-Q · filed 2016-08-04 | 71.55M shares 10-Q · filed 2016-08-04 | 68.64M shares derived: average of 3 quarters · filed 2017-03-16 | 67.19M shares derived: average of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | 66.67M shares 10-Q · filed 2016-05-09 | 64.78M shares derived: average of 2 quarters · filed 2017-03-16 | 64.13M shares derived: average of 3 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | 62.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 62.86M shares derived: average of 2 quarters · filed 2017-03-16 | 59.75M shares 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | 62.83M shares 10-Q · filed 2015-11-04 | 58.71M shares 10-Q · filed 2015-11-04 | |||||
| 2013-12-31 | 29.77M shares 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |